Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06111287
Other study ID # 1988
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2015
Est. completion date July 2020

Study information

Verified date October 2023
Source Azienda Sanitaria Locale Napoli 2 Nord
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This multicenter retrospective study analyzed data from 308 patients who underwent open Posterior Component separation with Trasversus release for primary or recurrent complex abdominal hernias between 2015 and 2020. The primary endpoint was the rate of Hernia Recurrence and Mesh Bulging at 3, 6, 12, 24, and 36 months. Secondary outcomes included surgical site events and were assessed using the Pain scale.


Description:

Study design This study is reported according to the STROBE statement for cohort studies A retrospective multicentric study was conducted to analyze the surgical outcomes of patients undergoing open with Posterior Component separation with Trasversus release for inisional hernia. It was conducted according to the ethical principles stated in the Declaration of Helsinki. Written informed consent was obtained from all subjects. Study setting and study population From January 2015 and May 2020, all the patients affected by primary or recurrent complex abdominal hernias undergoing open Posterior Component separation with Trasversus release referring to 6 centers, were considered for enrollment in the study. Inclusion criteria were age ≥16 years, primary or recurrent complex abdominal hernias with more than >10 cm midline defects Exclusion criteria were follow-up data lower than 36 months, patients with a stoma for whom closure was not planned during the abdominal hernia repair


Recruitment information / eligibility

Status Completed
Enrollment 432
Est. completion date July 2020
Est. primary completion date May 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - age =16 years, - primary or recurrent complex abdominal hernias with more than >10 cm midline defects Exclusion Criteria: - follow-up data lower than 36-months, patients with a stoma for whom closure was not planned during the abdominal hernia repair

Study Design


Locations

Country Name City State
Italy Francesco Pizza Naples
Italy Francdesco Pizza Napoli Naples

Sponsors (1)

Lead Sponsor Collaborator
Azienda Sanitaria Locale Napoli 2 Nord

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hernia Recurrence In details, Hernia Recurrence was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 3 months
Primary Hernia Recurrence In details, Hernia Recurrence was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 6 months
Primary Hernia Recurrence In details, Hernia Recurrence was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 12 months
Primary Hernia Recurrence In details, Hernia Recurrence was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 24 months
Primary Hernia Recurrence In details, Hernia Recurrence was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 36 months
Primary Mesh Bulging In details, Mesh Bulging was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 3 months
Primary Mesh Bulging In details, Mesh Bulging was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 12 months
Primary Mesh Bulging In details, Mesh Bulging was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 24 months
Primary Mesh Bulging In details, Mesh Bulging was clinically defined as any visible or palpable ''blowout'' in the abdominal wall. computed tomography scan evaluation was carried out by a radiologist with 10 years of gastrointestinal computed tomography scan experience. 36 months
Primary surgical site events Regarding the surgical site events, the classification of wound events was assigned according to the likelihood and degree of wound contamination at the time of the operation, as stated in the Centre for Disease Control and Prevention wound classification (superficial, deep or organ space) 1 months
Primary Number of patients affected by Superficial surgical site infection Superficial infections according to Clavien-Dindo criteria 1 months
Secondary Number of patients affected by Superficial surgical site infections Superficial infections according to Clavien-Dindo criteria Within 30 days postoperatively
Secondary Number of patients affected by Deep surgical site infections Deep surgical site infections according to Clavien-Dindo criteria Within 30 days postoperatively
Secondary Number of patients affected by organ space infections Organ space infections according to Clavien-Dindo criteria Within 30 days postoperatively
Secondary Number of patients affected by Surgical Site Occurence Surgical Site Occurence Reported according to the Ventral Hernia Working Group (VHWG) definitions Within 30 days postoperatively
Secondary Postoperative pain Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 1 month.
Secondary Postoperative pain Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 3 month.
Secondary Postoperative pain Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 6 month.
Secondary Postoperative pain Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 12 month.
Secondary Postoperative pain Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 24 month.
Secondary Postoperative pain Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 36 month.
See also
  Status Clinical Trial Phase
Recruiting NCT06051578 - Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
Completed NCT06034652 - T-GENVIH-003 LTFU (Long Term Follow Up) Study
Not yet recruiting NCT06060951 - Relating Abdominal Complications With Peritoneal Pressure Estimation and Reporting
Not yet recruiting NCT05467124 - Enhanced Recovery After Abdominal Wall Reconstruction
Terminated NCT02233569 - Comparison of Two Mesh/Fixation Concepts for Laparoscopic Ventral and Incisional Hernia Repair N/A
Completed NCT03458845 - Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal Hernia
Completed NCT02720042 - Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair N/A
Recruiting NCT04422197 - This Randomized Controlled Study Aims to Investigate the Effect of Botox Injection in Abdominal Wall Muscle Post Major Abdominal Surgery in Terms of Postoperative Pain, Incidence of Incisional Hernia. N/A
Not yet recruiting NCT06449378 - Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia N/A
Completed NCT01024296 - Efficacy Study to Evaluate Laparoscopic Fascial Closure Device N/A
Withdrawn NCT03792295 - Multimodal Pain Therapy After Hernia Repair Phase 2
Completed NCT02734563 - Collagen Alterations in Patients With Abdominal Wall Hernias N/A
Completed NCT03846661 - Nationwide Long-term Outcome Surveillance of Physiomesh® vs. Other Meshes in Laparoscopic Incisional Hernia Repair N/A
Completed NCT01268514 - ENHANCE: A Prospective EvaluatioN of Permacol™ in tHe Repair of Complex AbdomiNal Wall CasEs
Recruiting NCT04476212 - Prophylaxis of Surgical Wound Infection With Topical Antibiotics N/A
Recruiting NCT04516031 - Transversus Abdominis Muscle Release Versus Mesh Only Repair in the Treatment of Complex Ventral Wall Hernia N/A